NEW YORK (GenomeWeb) – IntegraGen today announced that its test kit for predicting patient response to anti-EGFR therapy has been CE-IVD marked, and the company will launch it in the European Union.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.